K-Dense-AI/scientific-agent-skills / skills/clinical-decision-support
clinical-decision-support
VerifiedPrepares and validates research-only clinical decision-support evaluation, evidence-profile, cohort, survival, biomarker/model, privacy, and governance artifacts. Supports aggregate or synthetic research documentation and traceability, excluding patient care and live clinical operation.
references/sources.md
View on GitHub# Authoritative Source Ledger
Documentation review: **2026-09-30**.
Reviewed official agencies, standards/guideline hosts, and primary publications using web search/read and fresh `parallel-cli extract` fallbacks. This skill has no runtime service endpoints, authentication, pagination, or external SDK dependencies: its seven CLIs consume local JSON. The optional collection-citation lookup is separate from artifact processing.
Status labels below reflect this review date. Some publisher/Bookshelf pages blocked direct reads; their indexed primary records, official guideline catalogues, or fresh extracts supplied the cited scope. A link is not an endorsement or a substitute for checking a living source before use. Tests use synthetic aggregates and establish helper behavior only, not clinical validity or compliance.
## FDA: CDS and AI-Enabled Devices
- **Clinical Decision Support Software** — FDA final guidance, January 2026; page reissued/content current January 29, 2026. Defines FDA's current interpretation of non-device CDS criteria and device-software boundaries.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
- **Marketing Submission Recommendations for a Predetermined Change Control Plan for AI-Enabled Device Software Functions** — FDA final guidance, August 2025. Used for planned modifications, validation methodology, impact assessment, and change-control concepts.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence
- **AI-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations** — FDA draft guidance, January 2025; explicitly draft/not for implementation on the cutoff date. Used only as clearly labeled draft lifecycle context.
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/artificial-intelligence-enabled-device-software-functions-lifecycle-management-and-marketing
- **Good Machine Learning Practice for Medical Device Development: Guiding Principles** — FDA page linking the January 2025 IMDRF final principles. Used for lifecycle, representative data, human-AI team, and independent testing themes.
https://www.fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices/good-machine-learning-practice-medical-device-development-guiding-principles
- **Transparency for Machine Learning-Enabled Medical Devices: Guiding Principles** — FDA/Health Canada/MHRA, June 13, 2024. Used for intended users, limitations, data characterization, uncertainty, human factors, monitoring, and update communication.
https://www.fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices/transparency-machine-learning-enabled-medical-devices-guiding-principles
- **Artificial Intelligence-Enabled Medical Devices** — current FDA topic page (redirect from the former software-as-a-medical-device route). Used to cross-check the guidance sequence.
https://www.fda.gov/medical-devices/digital-health-center-excellence/artificial-intelligence-enabled-medical-devices
## ONC / HTI-1
- **HTI-1 Final Rule** — official Federal Register text, January 2024. Used for the legal scope of predictive DSI/source-attribute and intervention-risk-management requirements.
https://www.federalregister.gov/citation/89-FR-1391
- **HTI-1 Decision Support Interventions Fact Sheet** — ONC, December 2023. Used for the section 170.315(b)(11) overview and predictive-DSI transparency categories.
https://www.healthit.gov/wp-content/uploads/2023/12/HTI-1_DSI_fact-sheet_508.pdf
- **Requirements for Decision Support Interventions and Predictive Models** — ONC final-rule presentation, January 18, 2024. Used for intended use, population, user, decision role, out-of-scope use, fairness, validation, performance, and maintenance source attributes.
https://healthit.gov/wp-content/uploads/2024/01/DSI_HTI1-Final-Rule-Presentation_508.pdf
- **HTI-1 Final Rule landing page** — ONC. Used to verify official supporting materials and current resource location.
https://healthit.gov/regulations/hti-rules/hti-1-final-rule
- **Current DSI certification text** — 45 CFR 170.315(b)(11); predictive DSI source-attribute and risk-management provisions remain in the current text.
https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-D/part-170/subpart-C/section-170.315
- **HTI-5 proposed rule** — proposal to remove AI model-card requirements; not treated as effective law.
https://healthit.gov/resources/health-data-technology-and-interoperability-astp-onc-deregulatory-actions-to-unleash-prosperity-hti-5-proposed-rule/
## GRADE
- **GRADE Working Group** — official overview and minimum requirements. Used for outcome-specific certainty, explicit domain judgments, evidence profiles, and Evidence-to-Decision separation.
https://www.gradeworkinggroup.org/
- **GRADE Book** — official current resource, progressively replacing the prior handbook by 2026. Used as the preferred methodology entry point.
https://book.gradepro.org/
- **GRADE Handbook** — legacy/current transition resource. Retained for comparison where a GRADE Book chapter is not yet available; verify against the GRADE Book.
https://gradepro.org/handbook
- **GRADE Book: Imprecision** — current chapter permits human judgments of serious, very serious, and extremely serious imprecision; supports explicit thresholds and uncertainty, not automatic grading.
https://book.gradepro.org/guideline/imprecision
- **GRADE Book: Dissemination bias** — current terminology broadens the legacy publication-bias assessment to selective availability. The local schema retains `publication_bias` as its field name.
https://book.gradepro.org/guideline/dissemination-bias
## AI and Clinical-Study Reporting
- **TRIPOD+AI** — Collins et al., BMJ 2024;385:e078378, published April 16, 2024. Reporting of prediction-model development/evaluation using regression or machine learning.
https://www.bmj.com/content/385/bmj-2023-078378
- **TRIPOD+AI EQUATOR record** — scope, checklist, and related materials.
https://www.equator-network.org/reporting-guidelines/tripod-statement
- **TRIPOD-LLM** — Gallifant et al., Nature Medicine 2025;31:60-69, published January 8, 2025. Modular reporting guidance for LLM development, tuning, and evaluation; not a quality appraisal tool.
https://www.nature.com/articles/s41591-024-03425-5
- **CONSORT-AI** — Liu et al., Nature Medicine 2020;26:1364-1374, published September 9, 2020. AI-intervention randomized-trial reports.
https://www.nature.com/articles/s41591-020-1034-x
- **CONSORT 2025** — Hopewell et al., BMJ 2025;389:e081123, published April 14, 2025. Current generic base statement used with CONSORT-AI.
https://www.bmj.com/content/389/bmj-2024-081123
- **SPIRIT-AI** — Rivera et al., Nature Medicine 2020;26:1351-1363, published September 9, 2020. AI-intervention trial protocols.
https://www.nature.com/articles/s41591-020-1037-7
- **SPIRIT 2025** — current generic base statement used with SPIRIT-AI.
https://pubmed.ncbi.nlm.nih.gov/40295741
- **DECIDE-AI** — Vasey et al., Nature Medicine 2022;28:924-933, published May 18, 2022. Early-stage live clinical evaluation of AI-based decision-support systems. Included for reporting context; live evaluation is outside this skill.
https://www.nature.com/articles/s41591-022-01772-9
- **DECIDE-AI EQUATOR record** — scope and publication links.
https://www.equator-network.org/reporting-guidelines/reporting-guideline-for-the-early-stage-clinical-evaluation-of-decision-support-systems-driven-by-artificial-intelligence-decide-ai/
- **STARD-AI** — Sounderajah et al., Nature Medicine, published September 15, 2025, DOI 10.1038/s41591-025-03953-8. Final reporting guideline for AI diagnostic-accuracy studies.
https://www.nature.com/articles/s41591-025-03953-8
- **STARD-AI author correction** — July 13, 2026; adds an omitted steering-committee author, with no checklist revision stated.
https://www.nature.com/articles/s41591-026-04570-9
- **SPIRIT-CONSORT official site and extension catalogue** — confirms current 2025 bases; AI extensions remain listed under the 2013/2010 bases, requiring an item-content crosswalk.
https://www.consort-spirit.org/
https://www.consort-spirit.org/extensions
- **STARD-AI EQUATOR record** — final status, scope, citation, and checklist location.
https://www.equator-network.org/reporting-guidelines/the-stard-ai-reporting-guideline-for-diagnostic-accuracy-studies-using-artificial-intelligence/
## Prediction-Model Risk of Bias
- **PROBAST+AI** — Moons et al., BMJ 2025;388:e082505, published March 24, 2025. Current quality/risk-of-bias/applicability tool for regression and AI prediction models; separates development from evaluation and uses participants/data sources, predictors, outcome, and analysis domains.
https://pubmed.ncbi.nlm.nih.gov/40127903
- **PROBAST+AI project site** — tool resources and updates.
https://www.probast.org/probast_ai
## Privacy and De-identification
- **HHS Guidance Regarding Methods for De-identification of PHI** — official OCR guidance, checked with current 45 CFR 164.514. Used for Expert Determination, Safe Harbor, actual knowledge, derivatives, and free-text cautions.
https://www.hhs.gov/hipaa/for-professionals/special-topics/de-identification/index.html
- **45 CFR 164.514** — current eCFR text for de-identification and related requirements.
https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.514
## ICH
- **ICH E6(R3) consolidated Step 4 guideline** — final version adopted June 16, 2026, consolidating principles, Annex 1, and Annex 2. Used for quality by design, fit-for-purpose data, oversight, privacy, auditability, and modern trial settings.
https://database.ich.org/sites/default/files/ICH%20E6(R3)_Step4_FinalConsolidatedGuideline_2026_0616_.pdf
- **ICH E9(R1) Addendum on Estimands and Sensitivity Analysis** — final, adopted November 20, 2019. Used for estimand-led planning and sensitivity analysis.
https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf
- **ICH efficacy-guideline index** — official status/version cross-check.
https://www.ich.org/page/efficacy-guidelines
## Cohort, Survival, and Biomarker Methods
- **STROBE** — official reporting guidance for observational studies.
https://www.strobe-statement.org/
- **RECORD** — reporting extension for routinely collected health data.
https://www.record-statement.org/
- **REMARK** — reporting recommendations for tumor-marker prognostic studies.
https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumour-marker-prognostic-studies-remark
- **FDA-NIH BEST Resource** — living biomarker and endpoint terminology resource, 2016 onward.
https://www.ncbi.nlm.nih.gov/books/NBK326791/
- **BEST Glossary** — revision January 16, 2025; includes multicomponent and response terminology. Direct Bookshelf reads returned a browser challenge; the indexed official glossary and FDA companion resource were used.
https://www.ncbi.nlm.nih.gov/books/NBK338448/
https://www.fda.gov/drugs/biomarker-qualification-program/about-biomarkers-and-qualification
- **Evaluation of clinical prediction models (part 2): how to undertake an external validation study** — Riley et al., BMJ 2024;384:e074820, published January 15, 2024. Used for locked-model evaluation, calibration, discrimination, utility, and transparent reporting.
https://www.bmj.com/content/384/bmj-2023-074820
- **External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb** — Snell et al., Journal of Clinical Epidemiology 2021;135:79-89. Used to reject blanket event-count rules and emphasize precision targets.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8352630
- **Calibration: the Achilles heel of predictive analytics** — Van Calster et al., BMC Medicine 2019. Used for calibration assessment and interpretation.
https://pubmed.ncbi.nlm.nih.gov/31842878
- **Restricted mean survival time** — Royston and Parmar, BMC Medical Research Methodology 2013;13:152. Used as an alternative population-level summary when proportional hazards is doubtful.
https://pubmed.ncbi.nlm.nih.gov/24314264/
- **Competing risks introduction** — Austin, Lee, and Fine, Circulation 2016;133:601-609. Used to distinguish cause-specific hazards, subdistribution hazards, and cumulative incidence.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4741409/
- **Fine-Gray reporting recommendations** — Austin and Fine, Statistics in Medicine 2017;36:4391-4400. Used for careful interpretation of subdistribution hazard models.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5698744
## Deliberately Out of Scope
HL7 CDS Hooks, SMART on FHIR, and FHIR implementation guidance were not
added because the version 2.0 safety redesign deliberately removes
recommendation-oriented and live CDS behavior. It produces offline
research/governance artifacts only; implementation guidance would conflict
with the hard boundary.
No source requiring an API key, external model, image generator, or network call is used at runtime.
Related skills
| Skill | Stars | Updated | Works with | Status | Install |
|---|---|---|---|---|---|
| rea-changelog-updatemorluto/reaPrepare or rewrite REA release changelogs and GitHub release notes from pinned Git history, with verified contributor thanks and Release Please synchronization. | Stars: 472k | Updated | Claude CodeCodex | Verified | Install |
| academy-guideanthropics/skillsStop and check this skill before finishing any reply to a question about how to use Claude or a Claude product — it recommends matching courses, tutorials, and use cases from Claude Academy (academy.claude.com), Anthropic's learning hub. Trigger on: "how do I", "how can I", "getting started with", "what can Claude do", "teach me", "learn to use"; questions about artifacts, projects, skills, plugins, connectors, MCP; requests about rolling Claude out to a team, class, or organization; and any ask for training materials, onboarding content, or learning resources. Use it when the user is learning how to use a feature or product — not when they are mid-task and just want the task done. This skill composes with other skills: after consulting product documentation to answer how a Claude feature works, also check here for a matching course or tutorial — a docs-grounded answer and an Academy recommendation belong together. Only recommend on a strong match; never invent Academy content. | Stars: 198k | Updated | Claude CodeCodex | Verified | Install |
| claude-apianthropics/skillsReference for the Claude API / Anthropic SDK — model ids, pricing, params, streaming, tool use, MCP, agents, caching, token counting, model migration. TRIGGER — read BEFORE opening the target file; don't skip because it "looks like a one-liner" — whenever: the prompt names Claude/Anthropic in any form (Claude, Anthropic, Fable, Opus, Sonnet, Haiku, `anthropic`, `@anthropic-ai`, `claude-*`, `us.anthropic.*`, `[1m]`); the user asks about an LLM (pricing/model choice/limits/caching) — never answer from memory; OR the task is LLM-shaped with provider unstated (agent/MCP/tool-definition/multi-agent/RAG/LLM-judge/computer-use; generate/summarize/extract/classify/rewrite/converse over NL; debugging refusals/cutoffs/streaming/tool-calls/tokens). SKIP only when another provider is being worked on (overrides all triggers): OpenAI/GPT/Gemini/Llama/Mistral/Cohere/Ollama named in the query; OR `grep -rE 'openai|langchain_openai|google.generativeai|genai|mistralai|cohere|ollama'` over the project hits (run this grep FIRST if no provider named — don't Read the file). | Stars: 198k | Updated | Claude CodeCodex | Unverified | Install |
| doc-coauthoringanthropics/skillsGuide users through a structured workflow for co-authoring documentation. Use when user wants to write documentation, proposals, technical specs, decision docs, or similar structured content. This workflow helps users efficiently transfer context, refine content through iteration, and verify the doc works for readers. Trigger when user mentions writing docs, creating proposals, drafting specs, or similar documentation tasks. | Stars: 198k | Updated | Claude CodeCodex | Verified | Install |